X4 Pharmaceuticals, Inc. 8-K Summary (11/05/2025)

X4 Pharmaceuticals, Inc. filed an 8-K reporting Q3 2025 financial results.

• Key Event: Furnishing of press release announcing financial results and business highlights for the third quarter ended September 30, 2025 (Item 2.02).
• Details: The actual financial metrics are contained in the furnished Exhibit 99.1 (Press Release).
• Stock Info: Trades on Nasdaq under the symbol XFOR.

*Note: Information furnished under Item 2.02 is not deemed “filed” for liability purposes unless expressly incorporated into a su